CN105675603A - Clinical symptom screening kit - Google Patents
Clinical symptom screening kit Download PDFInfo
- Publication number
- CN105675603A CN105675603A CN201610145029.8A CN201610145029A CN105675603A CN 105675603 A CN105675603 A CN 105675603A CN 201610145029 A CN201610145029 A CN 201610145029A CN 105675603 A CN105675603 A CN 105675603A
- Authority
- CN
- China
- Prior art keywords
- reagent
- substrate
- reagents
- symptom
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
Abstract
Provided is a clinical medical symptom screening kit. The clinical medial symptom screening kit comprises multiple reagents, multiple substrates and a reagent distributor; the reagents are used for indicating different medical symptoms; when each substrate receives one of the reagents, the substrate can present a first color, and when body fluid of a user with specific medical symptoms is added to the substrate, the color of the substrate can be changed into a second color from the first color; the reagent distributor is used for adding one of the reagents to one substrate; different dosages of different reagents are set according to inspection frequency of different symptoms.
Description
Technical field
The present invention relates to a kind of test kit, especially relate to a kind of clinical medicine symptom kit for screening.
Background technology
In prior art, medical personnel pass through the detection for body fluid such as blood, urine, saliva etc., for diagnosing the medical symptom of patient. To, in the detection of these body fluid, test kit is the detection device of a kind of routine. Generally including, in conventional test kit, the test paper prepared, test paper changes color when receiving patient body fluid so that medical personnel can judge the medical symptom of patient according to the color change of test paper.
The normally many test papers of test paper in existing test kit, such as, for the measurement of urine, usually use and survey Urine test paper more, this Urine test paper when producing just by plurality of reagents lamination, it is possible to other assays reaching 8 kinds in urine are carried out examination. But, when practical application, medical personnel may only want patient to carry out a kind of or two kinds detection, such as test for protein and glucose test. Testing by the urine of routine, medical personnel will be forced to use and survey Urine test paper more, and this Urine test paper is typically configured to nearly other assays of 8 kinds in urine are carried out examination. The Urine test paper using these routines is a kind of to the waste of material and money.
In order to solve the problem, 201280032981.7 patent of invention propose a kind of the detection kit, this test kit comprises multiple skip test bar and plurality of reagents, by the different reagent of distribution on skip test bar, for detecting different medical symptoms. That it changes the mode that can make test strip, provide necessary component to set up the customization test strip of low cost to medical personnel, these test strip can be used to the clinical diagnosis of patient and this patient carries out the examination of plurality of medical symptom effectively.
But, 201280032981.7 invention also there is following problem, on the one hand, in its technical scheme, the dosage of all ingredients is the same, but in clinical diagnosis, frequency different symptoms being needed to diagnosis is different, may cause when using like this, a certain reagent is finished and causes test kit to use, and other reagent also has residue, thus causes the waste of reagent; On the other hand, if when patient detects out certain symptom appearance positive, may also be continued to detect for this symptom later, cause the reagent dosage of this symptom very big, cause reagent to be finished very soon. And the invention of 201280032981.7 cannot solve the problem. The present invention as 201280032981.7 improvement, it is possible to solve the problem.
Summary of the invention
As an aspect of the present invention, it provides a kind of clinical medicine symptom kit for screening, comprising: plurality of reagents, it is used to indicate different medical symptom; Multiple substrates, described substrate receive in described plurality of reagents a kind of time, it is possible to presenting the first color, when adding the body fluid with the user of certain medical symptom to above-mentioned substrate, the color of this substrate can become second colors from the first color change; Reagent distributor; For the one in described plurality of reagents being added to a substrate; It is characterized in that: have different dosage in described plurality of reagents, described dosage is corresponding to the detection frequency of different reagent place instruction medical symptom.
Preferably, in technique scheme, described dosage is different according to the different steps of user's disease.
Preferably, in technique scheme, described dosage residing for user different steps between the Gestation period and different.
Preferably, in technique scheme, the first reagent in described plurality of reagents has the first dosage, when described first dosage occurs positive corresponding to user in the first medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection.
Preferably, in technique scheme, the 2nd reagent in described plurality of reagents has the 2nd dosage, when described 2nd dosage occurs positive corresponding to user in the 2nd medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection.
Preferably, in technique scheme, described first medical symptom and the 2nd medical symptom are two medically interrelated symptoms.
Preferably, in technique scheme, described first medical symptom is ketoacidosis, and the 2nd medical symptom is diabetes.
Preferably, in technique scheme, described first reagent is ketone reagent, and the 2nd reagent is glucose reagent.
Preferably, in technique scheme, comprising the first substrate and the 2nd substrate on described substrate, the every a slice in described first substrate is used for the detection of the reagent except the first reagent and the 2nd reagent, and described 2nd substrate is used for the first reagent and the 2nd reagent detects simultaneously.
Preferably, in technique scheme, described 2nd substrate is greater than the first substrate, is less than the twice of the first substrate.
Preferably, in technique scheme, described 2nd substrate arranging two regions, first area is used for the detection of the first reagent, and the 2nd region is used for the detection of the 2nd reagent.
As another aspect of the present invention, it provides the preparation method of a kind of clinical medicine symptom kit for screening, described medical symptom kit for screening comprises: plurality of reagents, is used to indicate different medical symptom; Multiple substrates, described substrate receive in described plurality of reagents a kind of time, it is possible to presenting the first color, when adding the body fluid with the user of certain medical symptom to above-mentioned substrate, the color of this substrate can become second colors from the first color change; Reagent distributor; For the one in described plurality of reagents being added to a substrate; The first reagent in described plurality of reagents has the first dosage, when described first dosage occurs positive corresponding to user in the first medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection; Described preparation method comprises the steps: to prepare above-mentioned plurality of reagents; Prepare multiple substrates above-mentioned; Preparation mentioned reagent divider; Plurality of reagents, multiple substrates and reagent distributor are assembled, generate polytype medical symptom kit for screening of different quantities, when there is the positive in the dissimilar a kind of detection corresponded in different medical symptom in described polytype medical symptom kit for screening, the medical symptom kit for screening of corresponding types;Wherein: the ratio that polytype medical symptom kit for screening number ratio of described different quantities occurs corresponding to different medical symptom.
Embodiment
The present invention will be described further in conjunction with specific embodiments, and these examples are only for illustration of object, and are not used in the restriction scope of the invention.
Embodiment one:
The present invention provides a kind of clinical medicine symptom kit for screening, comprises plurality of reagents, multiple substrates, reagent distributor and packing box. Wherein each in plurality of reagents is used to indicate different medical symptom, have been found that diagnosis and/or the screening agent of many types are all applicable to use together with the present invention, such as in obstetrics are detected, can the existence of examination following substances: albumen, glucose, nitrite, white corpuscle, ketoboidies, bilirubin and urobilinogen, separately add proportion and the pH level of this body fluid of inspection.
Multiple substrates, described substrate receive in described plurality of reagents a kind of time, it is possible to presenting the first color, when adding the body fluid with the user of certain medical symptom to above-mentioned substrate, the color of this substrate can become second colors from the first color change. Such as, it may also be useful to the protein reagent in 201280032981.7, when protein concentration scope is in 0.3-0.4g/L from yellow to blueness.
Reagent distributor, for adding a substrate to by the one in above-mentioned plurality of reagents. Packing box, its inside has accommodation space, described accommodation space for holding mentioned reagent, substrate and reagent distributor.
As the contribution of the present invention for prior art, having different dosage in the plurality of reagents in the present invention, dosage is corresponding to the detection frequency of different reagent place instruction medical symptom. Such as, in obstetrics check, each detection all needs detection albumen, and glucose detection only needs detection once, just no longer need detection after qualified, therefore, can by, in reagent, the amount of reagent of Protein Detection is set to relatively big, and the amount of reagent of glucose detection is set to less. So that when reagent detects, the consumption of all reagent is all comparatively even, avoids the waste of reagent. Preferably, due to the different steps in disease, the detection frequency of various symptom is also different, such as, the different steps of obstetrics between the Gestation period and the frequency that detects is different. Therefore, it is possible to according to the different stages, the dosage of all ingredients is set, makes the test kit being used in different steps and using.
When patient occurs positive for the diagnosis of certain symptom, such as, when diabetic symptom occurs in pregnant woman, periodic detection may be needed later. Therefore, for this kind of situation, it is possible to the glucose reagent in plurality of reagents is set to have the first dosage, when described first dosage occurs positive corresponding to user's diabetes, it is necessary to the dosage of the frequency of detection. In clinical detection, two medically interrelated symptoms, such as ketoacidosis and gestational diabetes, often may exist simultaneously. , it is possible to the ketone reagent in plurality of reagents is had the 2nd dosage, therefore when described 2nd dosage occurs positive corresponding to ketoacidosis, it is necessary to the dosage of the frequency of detection. Owing to these two kinds of symptoms need to detect simultaneously, can be set to substrate comprise the first substrate and the 2nd substrate, every a slice in described first substrate is used for the detection of the reagent except glucose reagent and ketone reagent, and the every a slice in described 2nd substrate is used for glucose reagent and ketone reagent detects simultaneously. Preferably, above-mentioned 2nd substrate arranging two regions, first area is used for the detection of the first reagent, and the 2nd region is used for the detection of the 2nd reagent. The area of above-mentioned 2nd substrate is greater than the first substrate, is less than the twice of the first substrate.
Embodiment two:
A preparation method for clinical medicine symptom kit for screening, described medical symptom kit for screening comprises: plurality of reagents, is used to indicate different medical symptom;Multiple substrates, described substrate receive in described plurality of reagents a kind of time, it is possible to presenting the first color, when adding the body fluid with the user of certain medical symptom to above-mentioned substrate, the color of this substrate can become second colors from the first color change; Reagent distributor; For the one in described plurality of reagents being added to a substrate; The first reagent in described plurality of reagents has the first dosage, when described first dosage occurs positive corresponding to user in the first medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection; Described preparation method comprises the steps: to prepare above-mentioned plurality of reagents; Prepare multiple substrates above-mentioned; Preparation mentioned reagent divider; Plurality of reagents, multiple substrates and reagent distributor are assembled, generate polytype medical symptom kit for screening of different quantities, when there is the positive in the dissimilar a kind of detection corresponded in different medical symptom in described polytype medical symptom kit for screening, the medical symptom kit for screening of corresponding types; The ratio that polytype medical symptom kit for screening number ratio of described different quantities occurs corresponding to different medical symptom. By the technical scheme of embodiment two, in process of production, occurrence rate for different medical symptom produces dissimilar medical symptom kit for screening number such that it is able to effectively improve the rate of utilization of reagent.
In the art, know for other reagent used together with test paper and test strip, and it is applicable to using together with the kit for screening of the present invention. Being not described further a bit, but it is believed that they also belong within the scope of the invention. In all documents incorporated by reference all in this application that the present invention mentions, just quoted separately as a reference as each section of document. In addition it will be understood that after the above-mentioned teachings having read the present invention, the present invention can be made various changes or modifications by those skilled in the art, these equivalent form of values fall within the application's appended claims limited range equally.
Claims (4)
1. a clinical medicine symptom kit for screening, comprising: plurality of reagents, is used to indicate different medical symptom; Multiple substrates, described substrate receive in described plurality of reagents a kind of time, it is possible to presenting the first color, when adding the body fluid with the user of certain medical symptom to above-mentioned substrate, the color of this substrate can become second colors from the first color change; Reagent distributor, for adding a substrate to by the one in described plurality of reagents; It is characterized in that: the first reagent in described plurality of reagents has the first dosage, when described first dosage occurs positive corresponding to user in the first medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection; The 2nd reagent in described plurality of reagents has the 2nd dosage, when described 2nd dosage occurs positive corresponding to user in the 2nd medical symptom that this kind of reagent is corresponding detects, it is necessary to the dosage of the frequency of detection; Comprising the first substrate and the 2nd substrate on described substrate, the every a slice in described first substrate is used for the detection of the reagent except the first reagent and the 2nd reagent, and described 2nd substrate is used for the first reagent and the 2nd reagent detects simultaneously.
2. clinical medicine symptom kit for screening according to claim 1, it is characterised in that: described 2nd substrate is greater than the first substrate, is less than the twice of the first substrate.
3. clinical medicine symptom kit for screening according to claim 2, it is characterised in that: arranging two regions on described 2nd substrate, described first area is used for the detection of the first reagent, and described 2nd region is used for the detection of the 2nd reagent.
4. a preparation method for the clinical medicine symptom kit for screening that one of claim 1-3 is described, comprises the steps: to prepare above-mentioned plurality of reagents; Prepare multiple substrates above-mentioned; Preparation mentioned reagent divider; Plurality of reagents, multiple substrates and reagent distributor are assembled, generate polytype medical symptom kit for screening of different quantities, when there is the positive in the dissimilar a kind of detection corresponded in different medical symptom in described polytype medical symptom kit for screening, the medical symptom kit for screening of corresponding types.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610145029.8A CN105675603B (en) | 2015-05-16 | 2015-05-16 | A kind of clinical symptoms kit for screening |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610145029.8A CN105675603B (en) | 2015-05-16 | 2015-05-16 | A kind of clinical symptoms kit for screening |
| CN201510249128.6A CN104807986B (en) | 2015-05-16 | 2015-05-16 | Clinical medicine symptom kit for screening |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510249128.6A Division CN104807986B (en) | 2015-05-16 | 2015-05-16 | Clinical medicine symptom kit for screening |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105675603A true CN105675603A (en) | 2016-06-15 |
| CN105675603B CN105675603B (en) | 2018-07-06 |
Family
ID=56310577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610145029.8A Active CN105675603B (en) | 2015-05-16 | 2015-05-16 | A kind of clinical symptoms kit for screening |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105675603B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109142339A (en) * | 2018-07-21 | 2019-01-04 | 贾晓轻 | The detection kit and application method |
| CN109187518A (en) * | 2018-08-04 | 2019-01-11 | 贾晓轻 | A kind of the detection kit |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030013121A1 (en) * | 2001-07-12 | 2003-01-16 | Khan Waheed N. | Diagnostic test kit |
| CN1495427A (en) * | 2002-08-21 | 2004-05-12 | ����ɨ������˾ | DIagnosis kit utilizing memory to store test strip calibration code and its related method |
| CN102590491A (en) * | 2012-02-06 | 2012-07-18 | 中国人民解放军第三军医大学第一附属医院 | Testing kit and testing method for early screening or assisting diagnosis of urinary system diseases as well as applications of testing kit and testing method |
| CN202362304U (en) * | 2011-09-16 | 2012-08-01 | 上海科新生物技术股份有限公司 | Kit |
| CN203224492U (en) * | 2013-03-08 | 2013-10-02 | 北京海瑞祥天生物科技有限公司 | Test strip and kit for in-vitro joint inspection and diagnosis |
| CN103649749A (en) * | 2011-05-06 | 2014-03-19 | 约翰霍普金斯大学 | Point-of-care, medical condition screening kit |
-
2015
- 2015-05-16 CN CN201610145029.8A patent/CN105675603B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030013121A1 (en) * | 2001-07-12 | 2003-01-16 | Khan Waheed N. | Diagnostic test kit |
| CN1495427A (en) * | 2002-08-21 | 2004-05-12 | ����ɨ������˾ | DIagnosis kit utilizing memory to store test strip calibration code and its related method |
| CN103649749A (en) * | 2011-05-06 | 2014-03-19 | 约翰霍普金斯大学 | Point-of-care, medical condition screening kit |
| CN202362304U (en) * | 2011-09-16 | 2012-08-01 | 上海科新生物技术股份有限公司 | Kit |
| CN102590491A (en) * | 2012-02-06 | 2012-07-18 | 中国人民解放军第三军医大学第一附属医院 | Testing kit and testing method for early screening or assisting diagnosis of urinary system diseases as well as applications of testing kit and testing method |
| CN203224492U (en) * | 2013-03-08 | 2013-10-02 | 北京海瑞祥天生物科技有限公司 | Test strip and kit for in-vitro joint inspection and diagnosis |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109142339A (en) * | 2018-07-21 | 2019-01-04 | 贾晓轻 | The detection kit and application method |
| CN109187518A (en) * | 2018-08-04 | 2019-01-11 | 贾晓轻 | A kind of the detection kit |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105675603B (en) | 2018-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tatapudi et al. | High prevalence of CKD of unknown etiology in Uddanam, India | |
| Akinsegun et al. | Mean platelet volume and platelet counts in type 2 diabetes: mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria | |
| von Dadelszen et al. | Pre-eclampsia: an update | |
| Shen et al. | Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X | |
| Cook et al. | Iron deficiency: definition and diagnosis | |
| Minutolo et al. | Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy | |
| Soubelet et al. | Correlates of level and change in the Mini-Mental State Examination. | |
| Toscani et al. | Predicting survival in terminal cancer patients: clinical observation or quality-of-life evaluation? | |
| Flynn | Microalbuminuria in children with primary hypertension | |
| Liu et al. | Executive summary: clinical practice guideline of chronic kidney disease–mineral and bone disorder (CKD-MBD) in China | |
| CN103293250B (en) | Diabetic nephropathy diagnostic kit and application thereof | |
| Dwarkanath et al. | Relationship of early vitamin D concentrations and gestational diabetes mellitus in Indian pregnant women | |
| CN106290890A (en) | The human body fluid development process fungus 1,3 β D glucosan detection kit of a kind of improvement and application process thereof | |
| CN105675603A (en) | Clinical symptom screening kit | |
| CN104807986B (en) | Clinical medicine symptom kit for screening | |
| Berktold et al. | Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening | |
| Goold et al. | Can fecal calprotectin serve as a screen for necrotizing enterocolitis in infants? | |
| Rassa et al. | Novel stratification of mortality risk by kidney disease stage | |
| Domislovic et al. | Should the CKD EPI equation Be used for estimation of the glomerular filtration rate in obese subjects? | |
| CN106570346A (en) | Physiological status assessment factor determination method and physiological status assessment factor determination system | |
| Neufeld et al. | Effects of preventive oral supplementation with iron or iron with folic acid for women following childbirth | |
| Alagiakrishnan et al. | Low agreement between the modified diet and renal disease formula and the Cockcroft-Gault formula for assessing chronic kidney disease in cognitively impaired elderly outpatients | |
| Ya et al. | Risk factors for higher volume of hemorrhage in ruptured anterior circulation intracranial aneurysms | |
| Böhmer et al. | Soluble transferrin receptor and iron status in elderly patients | |
| Ajuria-Morentin et al. | Determination of reference values for serum folate and vitamin B12 using three different immunoassays: is it worth making an effort to produce them in our laboratory? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180328 Address after: 100086 Beijing City, Haidian District Zhongguancun South Street No. 6 Zhucheng building block B room 1302 Applicant after: BEIJING ZHITAO SCIENCE & TECHNOLOGY CO., LTD. Address before: 050051 Heping West Road, Hebei, Shijiazhuang, No. 348 Applicant before: Jia Xiaoqing |
|
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Qiao Aijun Inventor before: Jia Xiaoqing |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180504 Address after: 100027 room 512, level five, building SOHO2, North Sanlitun Road, Chaoyang District, Beijing. Applicant after: Qiao Aijun Address before: 100086 room 1302, block B, casting tower, 6 South Avenue, Haidian District, Beijing, 6 Applicant before: BEIJING ZHITAO SCIENCE & TECHNOLOGY CO., LTD. |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant |